Hidenori Fukuoka Selected Research

Autoimmune Hypophysitis

11/2019	Pathogenesis of Anti-PIT-1 Antibody Syndrome: PIT-1 Presentation by HLA Class I on Anterior Pituitary Cells.
1/2017	A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.
10/2015	A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis.
2/2014	The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature.
1/2014	A missense single-nucleotide polymorphism in the sialic acid acetylesterase (SIAE) gene is associated with anti-PIT-1 antibody syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidenori Fukuoka Research Topics

Disease

24	Neoplasms (Cancer) 06/2022 - 01/2011
11	Pituitary Neoplasms (Pituitary Adenoma) 04/2022 - 10/2011
9	Acromegaly 01/2022 - 01/2008
7	Pituitary ACTH Hypersecretion 06/2022 - 12/2011
7	Hypophysitis 01/2022 - 10/2015
7	Hypothyroidism 12/2021 - 01/2011
5	Adrenocortical Adenoma (Disease, Conn's) 01/2022 - 01/2017
5	ACTH-Secreting Pituitary Adenoma 01/2021 - 04/2015
5	Autoimmune Hypophysitis 11/2019 - 01/2014
5	Non-alcoholic Fatty Liver Disease 01/2018 - 03/2007
4	Prolactinoma (Prolactinomas) 04/2022 - 01/2011
4	Cushing Syndrome 01/2022 - 01/2014
4	Adenoma (Adenomas) 01/2021 - 01/2011
4	Carcinogenesis 01/2015 - 08/2012
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022 - 01/2014
3	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 12/2021 - 10/2018
3	Carcinoma (Carcinomatosis) 04/2021 - 10/2018
3	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 01/2014
3	Pheochromocytoma 09/2020 - 01/2017
3	Paraganglioma (Paragangliomas) 01/2017 - 01/2014
3	Insulin Resistance 01/2017 - 03/2007
2	Hypopituitarism (Sheehan's Syndrome) 11/2022 - 02/2014
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2022 - 01/2018
2	Thymoma (Thymic Carcinoma) 03/2021 - 01/2020
2	Myxoma (Myxomas) 11/2020 - 01/2020
2	Growth Hormone-Secreting Pituitary Adenoma 10/2019 - 10/2018
2	Malnutrition (Nutritional Deficiencies) 01/2018 - 09/2013
2	Inflammation (Inflammations) 10/2016 - 07/2012
2	Obesity 01/2016 - 01/2013
2	Carney Complex 01/2014 - 01/2014
2	Multiple Endocrine Neoplasia Type 1 01/2014 - 01/2014
1	Hypotension (Low Blood Pressure) 11/2022
1	COVID-19 11/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 11/2022
1	Hyperaldosteronism (Conn Syndrome) 01/2022
1	Retinal Vasculitis 04/2021
1	Thyroiditis 04/2021
1	Lung Neoplasms (Lung Cancer) 04/2021
1	Nelson Syndrome 01/2021
1	Glucocorticoid Receptor Deficiency 11/2020
1	Insulinoma 09/2020

Drug/Important Bio-Agent (IBA)

15	Growth Hormone (Somatotropin)IBA 11/2022 - 03/2007
14	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2008
12	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2022 - 12/2011
8	ProlactinIBA 03/2021 - 01/2011
7	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 01/2014
7	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2008
6	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2021 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2011
5	Insulin (Novolin)FDA Link 11/2022 - 06/2010
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2021 - 12/2011
4	LigandsIBA 12/2021 - 01/2011
4	Tyrosine Kinase InhibitorsIBA 02/2017 - 10/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2012 - 03/2007
3	Dopamine Agonists (Dopamine Agonist)IBA 04/2022 - 01/2011
3	Temozolomide (Temodar)FDA LinkGeneric 04/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 01/2013
3	GlucocorticoidsIBA 06/2021 - 02/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 04/2015
3	Isolated ACTH DeficiencyIBA 01/2020 - 02/2014
3	ErbB Receptors (EGF Receptor)IBA 02/2017 - 01/2011
2	Capecitabine (Xeloda)FDA Link 04/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 03/2021 - 01/2020
2	Fumarate Hydratase (Fumarase)IBA 11/2020 - 01/2020
2	Octreotide (Sandostatin)FDA LinkGeneric 10/2018 - 01/2013
2	Hormones (Hormone)IBA 10/2018 - 01/2011
2	AntibodiesIBA 01/2018 - 09/2014
2	Gefitinib (Iressa)FDA Link 02/2017 - 12/2011
2	CorticosteroneIBA 02/2017 - 12/2011
2	Insulin-Like PeptidesIBA 01/2016 - 06/2012
2	Immunoglobulin G (IgG)IBA 10/2015 - 02/2014
2	Lapatinib (GW572016)FDA Link 01/2015 - 01/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2014 - 01/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 01/2014
2	Succinic Acid (Succinate)IBA 01/2014 - 01/2014
2	AntioxidantsIBA 03/2011 - 06/2010
1	Testosterone (Sustanon)FDA Link 11/2022
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 06/2022
1	amsonic acid (DAS)IBA 04/2022
1	Therapeutic UsesIBA 04/2022
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2022
1	Cytochrome P450 Family 11IBA 01/2022
1	AutoantigensIBA 12/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2021
1	AntigensIBA 12/2021
1	matrigelIBA 06/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021
1	Metyrapone FDA Link 06/2021
1	pembrolizumabIBA 04/2021
1	Prednisolone (Predate)FDA LinkGeneric 04/2021
1	AldosteroneIBA 09/2020
1	ReninIBA 09/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2020

Therapy/Procedure

14	Therapeutics 01/2019 - 01/2011
3	Radiotherapy 01/2022 - 12/2015
2	Immunotherapy 12/2021 - 01/2018
1	Critical Care (Surgical Intensive Care) 11/2022
1	Adrenalectomy 09/2020